China Universal

China Universal is a venture capital firm in Shanghai that focuses on a holistic approach. Founded in Shanghai, China, it invests in series B rounds. Its portfolio companies include TOT BIOPHARM. China Universal Asset Management has invested in TOT BIOPHARM on Aug 8, 2018. This investment in the Series B round of TOT BIOPHARM was valued at $102M. China Universal has formed six business areas, including mutual funds, internet finance, segregated account management, private equity, international business and pension management, through active equity investment, index investment, fixed Income investment, overseas investment and alternative investment. As of 2018 Q4, the company manages assets nearly RMB 700 billion and serve customers over 80 million.